期刊文献+

以CpG-ODN为佐剂的MAGE-n蛋白疫苗的免疫学作用及抗肿瘤效应 被引量:2

Immune responses and anti-tumor effects of melanoma antigen-n protein vaccine accompanied by CpG-containing oligodeoxynucleotide adjuvant
原文传递
导出
摘要 目的制备人黑色素瘤抗原-n(MAGE-n)蛋白疫苗,研究含CpG基序的寡聚脱氧核苷酸(CpG-ODN)联合MAGE-n蛋白疫苗,诱导小鼠产生的免疫应答,及在肿瘤免疫治疗中的作用。方法对含有MAGE-n原核表达质粒pGEX-MAGE-n的大肠杆菌DH5α进行诱导表达和分离纯化,作为MAGE-n蛋白疫苗,人工合成CpG-ODN作为佐剂,以C57BL/6小鼠为实验动物进行免疫接种;采用ELISPOT、LDH释放试验、血清ELISA法检测小鼠的细胞免疫和体液免疫反应;通过观察瘤体积和生存期了解疫苗的抗肿瘤效果。结果联合应用CpG-ODN和纯化的MAGE-n蛋白,能诱发C57BL/6小鼠产生较强的MAGE-n特异性的细胞和体液免疫应答;在MAGE-n阳性的B16肿瘤的免疫治疗中,可以减缓肿瘤的生长速度,延长荷瘤鼠的生存期。结论以CpG-ODN作为佐剂的MAGE-n蛋白疫苗,可以诱导C57BL/6小鼠产生MAGE-n特异性的免疫应答,对荷瘤鼠有较好的抗肿瘤效果,为肿瘤免疫治疗提供了一条新的途径。 Objective To prepare melanoma antigen n(MAGE-n)protein vaccine and to investigate the immune responses and antitumor effects of MAGE-n protein vaccine accompanied by CpG-containing oligodeoxynucleotide (CpG-ODN) adjuvant. Methods The DH5α containing the MAGE-n prokaryotic expression plasmid pGEX-MAGE-n was induced and the protein was purified as protein vaccine. The CpG-ODN was synthesized as adjuvant and the C57BL/6 mice were inoculated. The cellular and humoral immune responses were detected by ELISPOT, cytotoxicity assay and enzyme linked immunosorbent assay (ELISA). The antitumor effects were detected through tumor volume and life span. Results The MAGE-n protein accompanied by CpG-ODN could induce strong MAGE-n-specific cellular and humoral immune responses. In the MAGE-n positive B16 tumor model of C57BL/6, the growth velocity of tumor was decreased and the life span was prolonged with the treatment of vaccine. Conclusion MAGE-n protein vaccine accompanied by CpG-ODN adjuvant can induce strong immune responses and anti-tumor effects against MAGE-n positive B16 tumor, which provides a new way for tumor therapy.
出处 《中国医师杂志》 CAS 2006年第3期298-301,共4页 Journal of Chinese Physician
基金 国家自然科学基金(30271464) 全军医药卫生科研基金(01Z084)重点资助项目
关键词 黑色素瘤 抗原 肿瘤 疫苗 CPG岛 寡脱氧核糖核苷酸类 Melanoma Antigens, neoplasm Vaccines CpG islands Oligodeoxyribonucleotides
  • 相关文献

参考文献9

  • 1Marchand M,van Baren N,Weynants P,et al.Tumor regressions observed in patients with me-tastatic melanoma treated with an antigenic peptide encoded by gene MAGE 3 and presented by HLA A1.Int J Cancer,1999,80(2):219-230.
  • 2Krieg AM.Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides.Biochim Biophys Acta,1999,1489(1):107-116.
  • 3黄亚渝,隋延仿,叶菁,董海龙,陈广生,张秀敏.MAGE-n的原核表达与分离纯化[J].免疫学杂志,2004,20(2):103-105. 被引量:11
  • 4Krieg AM,Yi AK,Klinman DM,et al.CpG motif in bacterial DNA trigger direct B-cell activa-tion.Nature,1995,374:546-549.
  • 5van der Bruggen P,Traversari C,Chomez P,et al.A gene encoding an antigen recognized by cy-tolytic T lymphocytes on a human melanoma.Science,1991,254(5038):1643-1647.
  • 6武文,隋延仿,叶菁,李增山,郭爱林,杨欣伟,曲萍,张秀敏.人肝癌细胞系中肿瘤相关基因MAGE的克隆[J].细胞与分子免疫学杂志,2002,18(3):270-273. 被引量:10
  • 7董海龙,隋延仿,叶菁,李增山,曲萍,张秀敏,陈广生,禄韶英.肿瘤抗原MAGE-n HLA-A2限制性细胞毒性T细胞表位的预测及合成鉴定[J].中华医学杂志,2003,83(12):1080-1083. 被引量:10
  • 8Hai-Long Dong,Zeng-Shan Li,Jing Ye,et al.Identification of HLA-A2-restricted CTL epitope encoded by MAGE-n gene of human heaptocellular.Cancer biology&therapy,2004,3(9):891-898.
  • 9Ye J,Chen GS,Song HP,et al.Heatshock protein 70/MAGE-1 tumor vaccine can enhance the potency of MAGE-1-specific cellular immune responses in vivo.Cancer Immunol Immuno Ther,2004,53:825-834.

二级参考文献34

  • 1[1]van der Bruggen P,Traversari C,Chomez P,et al.A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma[J].Science,1991,254(5038):1643-1647.
  • 2[2]Gaugler B,Olive D.Tumor antigens recognized by T-lymphocytes in human cancers.New advances and therapeutic perspectives[J].Pathol Biol (Paris),1998,46(10):771-778.
  • 3[3]Tahara K,Mori M,Sadanaga N,et al.Expression of the MAGE gene family in human hepatocellular carcinoma[J].Cancer,1999,85(6):1234-1240.
  • 4[4]Tartaglia J,Bonnet MC,Berinstein N,et al.Therapeutic vaccines against melanoma and colorectal cancer[J].Vaccine,2001,19(17-19):2571-2575.
  • 5[5]Forslund K,Nordqvist K.The melanoma antigen genes-any clues to their functions in normal tissues[J].Exp Cell Res,2001,265(2):185-194.
  • 6[6]Sadanaga N,Nagashima H,Mashino K,et al.Dendritic cell vaccination with mage peptide is a novel therapeutic approach for gastrointestinal carcinomas[J].Clin Cancer Res,2001,7(8):2277-2284.
  • 7[7]Dutoit V,Rubio-Godoy V,Dietrich PY,et al.Heterogeneous T-cell response to MAGE-A10(254-262):high avidity-specific cytolytic T lymphocytes show superior antitumor activity[J].Cancer Res,2001,61(15):5850-5856.
  • 8[8]Griffioen M,Borghi M,Schrier PI,et al.Detection and quantification of CD8+T cells specific for HLA-A*0201-binding melanoma and viral peptides by the IFN-gamma-ELISPOT assay[J].Int J Cancer,2001,93(4):549-555.
  • 9[9]Beck A,Bussat MC,Klinguer-Hamour C,et al.Stability and CTL activity of N-terminal glutamic acid containing peptides[J].J Pept Res,2001,57(6):528-538.
  • 10[10]Chaux P,Lethe B,Van Snick J,et al.A MAGE-1 peptide recognized on HLA-DR15 by CD4+T cells[J].Eur J Immunol,2001,31(6):1910-1916.

共引文献21

同被引文献10

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部